The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Rings in Clinical Trials and Drugs: Present and Future
Open accessAbstract
We present a comprehensive analysis of all ring systems (both heterocyclic and nonheterocyclic) in clinical trial compounds and FDA-approved drugs. We show 67% of small molecules in clinical trials comprise only ring systems found in marketed drugs, which mirrors previously published findings for newly approved drugs. We also show there are approximately 450 000 unique ring systems derived from 2.24 billion molecules currently available in synthesized chemical space, and molecules in clinical trials utilize only 0.1% of this available pool. Moreover, there are fewer ring systems in drugs compared with those in clinical trials, but this is balanced by the drug ring systems being reused more often. Furthermore, systematic changes of up to two atoms on existing drug and clinical trial ring systems give a set of 3902 future clinical trial ring systems, which are predicted to cover approximately 50% of the novel ring systems entering clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Community structure in social and biological networks
Girvan, M., & Newman, M. E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122653799 · Cited by 15,502
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
PubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Handbook of Molecular Descriptors
Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107
Rings in Drugs: Miniperspective
Taylor, R. D., MacCoss, M., & Lawson, A. D. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4017625 · Cited by 2,543
Self-citationZINC: A Free Tool to Discover Chemistry for Biology
Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3001277 · Cited by 2,509
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,482
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
Best Practices for QSAR Model Development, Validation, and Exploitation
Tropsha, A. (2010) · Molecular Informatics · doi:10.1002/minf.201000061 · Cited by 2,024
Estimation of clinical trial success rates and related parameters
Wong, C. H., Siah, K. W., & Lo, A. W. (2019) · Biostatistics · doi:10.1093/biostatistics/kxx069 · Cited by 1,585
Privileged scaffolds for library design and drug discovery
Welsch, M. E., Snyder, S. A., & Stockwell, B. R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.018 · Cited by 1,509
Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17
Ruddigkeit, L., van Deursen, R., Blum, L. C., & Reymond, J.-L. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300415d · Cited by 1,505
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
Ultra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
970 Million Druglike Small Molecules for Virtual Screening in the Chemical Universe Database GDB-13
Blum, L. C., & Reymond, J.-L. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902302h · Cited by 860
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
Ajay, Walters, W. P., & Murcko, M. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970666c · Cited by 484
The Scaffold Tree − Visualization of the Scaffold Universe by Hierarchical Scaffold Classification
Schuffenhauer, A., Ertl, P., Roggo, S., Wetzel, S., Koch, M. A., & Waldmann, H. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600338x · Cited by 364
Böhm, H.-J., Flohr, A., & Stahl, M. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.10.009 · Cited by 335
Heteroaromatic Rings of the Future
Pitt, W. R., Parry, D. M., Perry, B. G., & Groom, C. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801513z · Cited by 332
The 'rule of three' for fragment-based drug discovery: where are we now?
Jhoti, H., Williams, G., Rees, D. C., & Murray, C. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3926-c1 · Cited by 328
Kim, J., Kim, H., & Park, S. B. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508343a · Cited by 308
Matched Molecular Pairs as a Medicinal Chemistry Tool: Miniperspective
Griffen, E., Leach, A. G., Robb, G. R., & Warner, D. J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200452d · Cited by 282
Recognizing molecules with drug-like properties
Walters, W. P., Murcko, A. A., & Murcko, M. A. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80058-1 · Cited by 266
Ertl, P., Jelfs, S., Mühlbacher, J., Schuffenhauer, A., & Selzer, P. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060217p · Cited by 254
SureChEMBL: a large-scale, chemically annotated patent document database
Papadatos, G., Davies, M., Dedman, N., Chambers, J., Gaulton, A., Siddle, J., Koks, R., Irvine, S. A., Pettersson, J., Goncharoff, N., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1253 · Cited by 229
Identification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms
Gillet, V. J., Willett, P., & Bradshaw, J. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci970431+ · Cited by 176
Similarity Searching Using 2D Structural Fingerprints
Willett, P. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-839-3_5 · Cited by 155
Drug discovery in the next decade: innovation needed ASAP
Bennani, Y. L. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.004 · Cited by 120
HierS: Hierarchical Scaffold Clustering Using Topological Chemical Graphs
Wilkens, S. J., Janes, J. O., & Su, A. I. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049032d · Cited by 101
The Making of Reaxys—Towards Unobstructed Access to Relevant Chemistry Information
Lawson, A. J., Swienty-Busch, J., Géoui, T., & Evans, D. (2014) · ACS symposium series · doi:10.1021/bk-2014-1164.ch008 · Cited by 91
Self-citationPatel, H., Ihlenfeldt, W. D., Judson, P. N., Moroz, Y. S., Pevzner, Y., Peach, M. L., Delannée, V., Tarasova, N. I., & Nicklaus, M. C. (2020) · Scientific Data · doi:10.1038/s41597-020-00727-4 · Cited by 81
Similarity Measure for Molecular Structure: A Brief Review
Bero, S. A., Muda, A. K., Choo, Y., Muda, N. A., & Pratama, S. F. (2017) · Journal of Physics Conference Series · doi:10.1088/1742-6596/892/1/012015 · Cited by 74
Sidorov, P., Gaspar, H. A., Marcou, G., Varnek, A. A., & Horvath, D. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9882-z · Cited by 68
Combining Molecular Scaffolds from FDA Approved Drugs: Application to Drug Discovery
Taylor, R. D., MacCoss, M., & Lawson, A. D. G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01367 · Cited by 62
Self-citationIntuitive Ordering of Scaffolds and Scaffold Similarity Searching Using Scaffold Keys
Ertl, P. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5001983 · Cited by 60
Kombarov, R. V., Altieri, A., Genis, D. V., Kirpichenok, M., Kochubey, V. V., Rakitina, N., & Titarenko, Z. Y. (2009) · Molecular Diversity · doi:10.1007/s11030-009-9157-5 · Cited by 57
Virtual Exploration of the Ring Systems Chemical Universe
Visini, R., Arús‐Pous, J., Awale, M., & Reymond, J. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00457 · Cited by 49
Magic Rings: Navigation in the Ring Chemical Space Guided by the Bioactive Rings
Ertl, P. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00761 · Cited by 43
Current kinase inhibitors cover a tiny fraction of fragment space
Zhao, H., & Caflisch, A. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.005 · Cited by 24
Metadata
- Authors
- Shearer, J., Castro, J. L., Lawson, A. D. G., MacCoss, M., & Taylor, R. D.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-06-22
- Volume
- 65
- Issue
- 13
- Pages
- 8699-8712
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W4283317658
- Cited by
- 479
- References
- 46
- FWCI
- 44.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.